Plain English Breakdown
The plain English breakdown is still being put together. The official documents below are already here.
HB2057 • 2025
Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers from requiring that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug.
Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers from requiring that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug.
Passed Legislature
This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.
Bill History
-
2025-06-27
House
In committee upon adjournment.
-
2025-04-01
House
Work Session held.
-
2025-03-11
House
Public Hearing held.
-
2025-01-17
House
Referred to Behavioral Health and Health Care.
-
2025-01-13
House
First reading. Referred to Speaker's desk.
Official Summary Text
Digest: Tells insurers and PBMs not to require that drugs be labeled as 340B drugs in a claim for repayment. (Flesch Readability Score: 62.8). Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers from requiring that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug. Takes effect on the 91st day following adjournment sine die. Relating to: Relating to prescription drugs; prescribing an effective date. Current location: In House Committee Awaiting transfer to Desk